CRT 2017: ACS & AMI Management - STEMI 2017 Hot Topic: Multivessel Disease Treatment

Conference

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

ACS & AMI Management - STEMI 2017 Hot Topic: Multivessel Disease Treatment

Featuring

  • Michael Lipinski
  • Barry Rutherford
  • Timothy Henry
  • Gregg Stone
  • George Dangas
  • Pieter Smits
  • Paul Gurbel
  • Dominick Angiolillo
  • Eric Bates

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$14.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

Case Introduction: A STEMI Patient with Multivessel Disease - Michael Lipinski
Culprit Only Versus Multivessel Intervention in STEMI: A Word of Caution - Barry Rutherford
Culprit Only Versus Multivessel Intervention in STEMI: Treat Them All! - Timothy Henry
Should Cangrelor Be Used in Most STEMI Patients? - Gregg Stone
Optimal Anticoagulation for Patients With STEMI Bivalirudin Versus Heparin: What Should Be the Standard of Care in 2017? - George Dangas
Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease? - Pieter Smits
With Ticagrelor and Crushing, Cangrelor Has Only a Niche Role - Paul Gurbel
What Should Be the Optimal Duration of DAPT in Patients With STEMI? - Dominick Angiolillo
When and How Should We Use Lytics in STEMI? - Eric Bates

Target Audience

  • Cardiologists
  • Interventional Cardiologists
  • Interventional Fellows
  • Interventional Radiologists
  • Vascular Surgeons
  • Emergency Physicians
  • Physicians with an interest in Cardiovascular Innovations

Learning Objectives

Related Moments

CRT 2017: ACS & AMI Management - Things to Know
Conference
Alcohol Septal Ablation For The Treatment Of Hypertrophic Obstructive Cardiomyopathy
Journal
Article on Alcohol Septal Ablation For The Treatment Of Hypertrophic Obstructive Cardiomyopathy
CRT 2016 Technology & Innovation - Japan FDA: Japan - US Synergies In The Second Decade - Opening Perspectives
Conference
A session explaining Japan - US Synergies In The Second Decade from CRT 2016
Loading Simple Education